Pete Najarian Sees Unusual Options Activity In SPDR S&P Biotech


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about high options volume in SPDR S&P Biotech (ETF) (NYSE:XBI).

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

He said that around 22,000 contracts of the November 90 calls were bought for $2. It's unusual to see that much volume in SPDR S&P Biotech, explained Najarian. The trade breaks even at $92 or 4.26 percent above the current market price. Najarian decided to follow the trade.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: CNBCOptionsMarketsMediaETFsFast Money Halftime ReportPete Najarian